A phase IIIb, multicentre, randomised, parallel-group, placebo-controlled, double-blind study to investigate the efficacy and safety of OROS hydromorphone in subjects with moderate-to-severe chronic pain induced by osteoarthritis of the hip or the knee

Pain Research and Treatment

Volumn 2011, Issue , 2011, Pages

  Vojtaššák, Jozef ^a   Jacobs, Adam ^b   Rynn, Leonie ^c   Waechter, Sandra ^d   Richarz, Ute ^e  

^a Orthos Paidion   (Slovakia)

^b Dianthus Medical Limited   (United Kingdom)

^c Analgesia Janssen Cilag Quarryvale   (Ireland)

^d Medical Affairs   (Switzerland)

^e JOHNSON AND JOHNSON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84863682692     PISSN: 20901542     EISSN: 20901550     Source Type: Journal    
DOI: 10.1155/2011/239501     Document Type: Review

References (36)

1. Brennan F., Cousins M. J., Pain relief as a human right. Pain Clinical Updates 2004 12 5 2-s2.0-33645231857 10.1016/j.ejpain.2005.06.009
2. Harstall C., Ospina M., How prevalent is chronic pain? Pain Clinical Updates 2003 11 2 2-s2.0-33645231857 10.1016/j.ejpain.2005.06.009
3. Breivik H., Collett B., Ventafridda V., Cohen R., Gallacher D., Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment. European Journal of Pain 2006 10 4 287 333 2-s2.0-33645231857 10.1016/j.ejpain.2005.06.009
4. Chronic Pain in America: Roadblocks to Relief, a study conducted by Roper Starch Worldwide for American Academy of Pain Medicine, American Pain Society and Janssen Pharmaceutica, 1999. 2010. http://www.ampainsoc.org/links/ roadblocks/
5. Grammas D. A., Lane N. E., Weismann M. H., Weinblatt M. E., Osteoarthritis. Treatment of the Rheumatic Diseases 2005 25 Philadelphia, Pa, USA Saunders 1 24
6. Lawrence J. S., Bremner J. M., Bier F., Osteoarthritis: prevalence in the population and relationship between symptoms and X-ray changes. Annals of the Rheumatic Diseases 1966 25 1 1 24 2-s2.0-0013874373
7. National Centre of Health Statistic: prevalence of osteoarthritis in adults by age, sex, race, and geographic areas: United States, 1960-1962. Vital and Health Statistics 1966 15 11
8. Manek N. J., Lane N. E., Osteoarthritis: current concepts in diagnosis and management. American Family Physician 2000 61 6 1795 1804 2-s2.0-0034653742
9. Lawrence R. C., Felson D. T., Helmick C. G., Arnold L. M., Choi H., Deyo R. A., Gabriel S., Hirsch R., Hochberg M. C., Hunder G. G., Jordan J. M., Katz J. N., Kremers H. M., Wolfe F., Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis and Rheumatism 2008 58 1 26 35 2-s2.0-38149052992 10.1002/art.23176
10. Zhang W., Moskowitz R. W., Nuki G., Abramson S., Altman R. D., Arden N., Bierma-Zeinstra S., Brandt K. D., Croft P., Doherty M., Dougados M., Hochberg M., Hunter D. J., Kwoh K., Lohmander L. S., Tugwell P., OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis and Cartilage 2008 16 2 137 162 2-s2.0-38949130488 10.1016/j.joca.2007.12.013
11. Noble M., Treadwell J. R., Tregear S. J., Coates V. H., Wiffen P. J., Akafomo C., Schoelles K. M., Long-term opioid management for chronic noncancer pain. Cochrane Database of Systematic Reviews 2010 1 CD006605 2-s2.0-77950898278
12. Trescot A. M., Glaser S. E., Hansen H., Benyamin R., Patel S., Manchikanti L., Effectiveness of opioids in the treatment of chronic non-cancer pain. Pain Physician 2008 11 2 S181 S200 2-s2.0-43649086219
13. Ballantyne J. C., Opioid analgesia: perspective on right use and utility. Pain Physician 2007 10 3 479 491 2-s2.0-34250888139
14. Furlan A. D., Sandoval J. A., Mailis-Gagnon A., Tunks E., Opioids for chronic noncancer pain: a meta-analysis of effectiveness and side effects. Canadian Medical Association Journal 2006 174 11 1589 1594 2-s2.0-33646851193 10.1503/cmaj.051528
15. Kalso E., Edwards J. E., Moore R. A., McQuay H. J., Opioids in chronic non-cancer pain: systematic review of efficacy and safety. Pain 2004 112 3 372 380 2-s2.0-9244233833 10.1016/j.pain.2004.09.019
16. Chou R., Clark E., Helfand M., Comparative efficacy and safety of long-acting oral opioids for chronic non-cancer pain: a systematic review. Journal of Pain and Symptom Management 2003 26 5 1026 1048 2-s2.0-0142247297 10.1016/j.jpainsymman.2003.03.003
17. Ballantyne J. C., Mao J., Opioid Therapy for Chronic Pain. New England Journal of Medicine 2003 349 20 1943 1953 2-s2.0-0242658912 10.1056/NEJMra025411
18. McNicol E., Opioid side effects. Pain Clinical Updates 2007 15 2 2-s2.0-0242658912 10.1056/NEJMra025411
19. Nüesch E., Rutjes A. W., Husni E., Welch V., Jüni P., Oral or transdermal opioids for osteoarthritis of the knee or hip. Cochrane Database of Systematic Reviews 2009 4 CD003115 2-s2.0-75349083835
20. Jovey R. D., Ennis J., Gardner-Nix J., Faura C. C., Ilias W. K., Jensen T. S., Perrot S., Plaghki L. H., Zenz M., Use of opioid analgesics for the treatment of chronic noncancer pain-a consensus statement and guidelines from the Canadian Pain Society, 2002. Pain Research & Management 2003 8 supplement A 3A 28A 2-s2.0-0041909442 10.1016/S1090-3801(02)00143-X
21. Kalso E., Allan L., Dellemijn P. L., Faura C. C., Ilias W. K., Jensen T. S., Perrot S., Plaghki L. H., Zenz M., Recommendations for using opioids in chronic non-cancer pain. European Journal of Pain 2003 7 5 381 386 2-s2.0-0041909442 10.1016/S1090-3801(02)00143-X
22. AGS Panel on Persistent Pain in Older Persons, The management of persistent pain in older persons. Journal of the American Geriatrics Society 2002 50 6 S205 S224 2-s2.0-0036087972
23. Vallerand A. H., The use of long-acting opioids in chronic pain management. Nursing Clinics of North America 2003 38 3 435 445 2-s2.0-0142212136 10.1016/S0029-6465(02)00094-4
24. Koizumi W., Toma H., Watanabe K., Katayama K., Kawahara M., Matsui K., Takiuchi H., Yoshino K., Araki N., Kodama K., Kimura H., Kono I., Hasegawa H., Hatanaka K., Hiraga K., Takeda F., Efficacy and tolerability of cancer pain management with controlled-release oxycodone tablets in opioid-naive cancer pain patients, starting with 5 mg tablets. Japanese Journal of Clinical Oncology 2004 34 10 608 614 2-s2.0-20844450740 10.1093/jjco/hyh104
25. Pan H., Zhang Z., Zhang Y., Xu N., Lu L., Dou C., Guo Y., Wu S., Yue J., Wu D., Dai Y., Efficacy and tolerability of oxycodone hydrochloride controlled-release tablets in moderate to severe cancer pain. Clinical Drug Investigation 2007 27 4 259 267 2-s2.0-33947327851 10.2165/00044011-200727040- 00005
26. Rauck R., Ma T., Kerwin R., Ahdieh H., Titration with oxymorphone extended release to achieve effective long-term pain relief and improve tolerability in opioid-naive patients with moderate to severe pain. Pain Medicine 2008 9 7 777 785 2-s2.0-52949098347 10.1111/j.1526-4637.2007.00390.x
27. ® hydromorphone and twice-daily extended-release oxycodone in patients with chronic, moderate to severe osteoarthritis pain: results of a 6-week, randomized, open-label, noninferiority analysis. Clinical Therapeutics 2007 29 5 874 888 2-s2.0-34547663283 10.1016/j.clinthera.2007.05.016
28. JurnistaTM monograph, Janssen Cilag. 2006
29. Gupta S., Sathyan G., Providing Constant Analgesia with OROS Hydromorphone. Journal of Pain and Symptom Management 2007 33 2S S19 S24 2-s2.0-33846616344 10.1016/j.jpainsymman.2006.09.009
30. Dworkin R. H., Turk D. C., Peirce-Sandner S., McDermott M. P., Farrar J. T., Hertz S., Katz N. P., Raja S. N., Rappaport B. A., Placebo and treatment group responses in postherpetic neuralgia vs. painful diabetic peripheral neuropathy clinical trials in the REPORT database. Pain 2010 150 1 12 16 2-s2.0-77953020404 10.1016/j.pain.2010.02.002
31. Data on file Mountainview, CA, USA ALZA Corporation
32. Turner J. A., Deyo R. A., Loeser J. D., Von Korff M., Fordyce W. E., The importance of placebo effects in pain treatment and research. Journal of the American Medical Association 1994 271 20 1609 1614 2-s2.0-0028242319 10.1001/jama.271.20.1609
33. Oken B. S., Placebo effects: clinical aspects and neurobiology. Brain 2008 131 11 2812 2823 2-s2.0-55749111215 10.1093/brain/awn116
34. White D. K., Keysor J. J., LaValley M. P., Lewis C. E., Torner J. C., Nevitt M. C., Felson D. T., Clinically important improvement in function is common in people with or at high risk of knee OA: the MOST study. Journal of Rheumatology 2010 37 6 1244 1251 2-s2.0-77953223650 10.3899/jrheum.090989
35. Langford R., McKenna F., Ratcliffe S., Vojtaššák J., Richarz U., Transdermal fentanyl for improvement of pain and functioning in osteoarthritis: a randomized, placebo-controlled trial. Arthritis and Rheumatism 2006 54 6 1829 1837 2-s2.0-33745047964 10.1002/art.21884
36. Zhang W., Doherty M., Arden N., Bannwarth B., Bijlsma J., Gunther K. P., Hauselmann H. J., Herrero-Beaumont G., Jordan K., Kaklamanis P., Leeb B., Lequesne M., Lohmander S., Mazieres B., Martin-Mola E., Pavelka K., Pendleton A., Punzi L., Swoboda B., Varatojo R., Verbruggen G., Zimmermann-Gorska I., Dougados M., EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Annals of the Rheumatic Diseases 2005 64 5 669 681 2-s2.0-20244375984 10.1136/ard.2004.028886